Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials

키워드

참고문헌 (29)

1. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회[DOI]
2. 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2013", Cancer Research and Treatment, 45(1), pp.15~21 (2013), 대한암학회[DOI]
3. Neugut AI, "Duration of adjuvant chemotherapy for colon cancer and survival among the elderly", J Clin Oncol, 24, pp.2368~2375 (2006)
4. Sakuramoto S, "Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine", N Engl J Med, 357, pp.1810~1820 (2007)
5. Sasako M, "Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer", J Clin Oncol, 29, pp.4387~4393 (2011)
6. Noh SH, "Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy(CLASSIC) : 5-year follow-up of an openlabel, randomised phase 3 trial", Lancet Oncol, 15, pp.1389~1396 (2014)
7. Bang YJ, "Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy(CLASSIC) : a phase 3 open-label, randomised controlled trial", Lancet, 379, pp.315~321 (2012)
8. Bouche O, "Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer : 7-year results of the FFCD randomized phase III trial(8801)", Ann Oncol, 16, pp.1488~1497 (2005)
9. Nakajima T, "Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer", Br J Surg, 94, pp.1468~1476 (2007)
10. Cascinu S, "Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial", J Natl Cancer Inst, 99, pp.601~607 (2007)
11. Fazio N, "Re : Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial", J Natl Cancer Inst, 99, pp.1345~1346 (2007)
12. De Vita F, "Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients : a randomized phase III trial by the Gruppo Oncologico Italia Meridionale(GOIM 9602 Study)", Ann Oncol, 18, pp.1354~1358 (2007)
13. Paganini-Hill A, "Activities and mortality in the elderly : the Leisure World cohort study", J Gerontol A Biol Sci Med Sci, 66, pp.559~567 (2011)
14. Molineux M, "Social and productive activities in elderly people. Activity (occupation) is important for survival", BMJ, 320, pp.184~185 (2000)
15. Tournigand C, "Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients(between ages 70and 75 years)with colon cancer : subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial", J Clin Oncol, 30, pp.3353~3360 (2012)
16. Huguenin P, "Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy", J Clin Oncol, 22, pp.4665~4673 (2004)
17. Hogberg T, "Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer : results from two randomised studies", Eur J Cancer, 46, pp.2422~2431 (2010)
18. Inoshita N, "Pathological characteristics of gastric carcinomas in the very old", Jpn J Cancer Res, 89, pp.1087~1092 (1998)
19. Arai T, "Pathologic characteristics of gastric cancer in the elderly : a retrospective study of 994 surgical patients", Gastric Cancer, 7, pp.154~159 (2004)
20. Cancer Genome Atlas Research Network, "Comprehensive molecular characterization of gastric adenocarcinoma", Nature, 513, pp.202~209 (2014)
21. Habu H, "Gastric cancer in elderly patients : results of surgical treatment", Hepatogastroenterology, 36, pp.71~74 (1989)
22. 최주영, "노인 위암 환자의 임상적 및 병리적 특징과 수술 시행에 따른 생존율 차이", 대한소화기학회지, 58(1), pp.9~19 (2011), 대한소화기학회
23. Kitamura K, "Clinicopathological characteristics of gastric cancer in the elderly", Br J Cancer, 73, pp.798~802 (1996)
24. Edelman DS, "Gastric cancer in the elderly", Am Surg, 53, pp.170~173 (1987)
25. Ishigami S, "Clinical and pathologic features of early gastric cancer in elderly patients", Hepatogastroenterology, 44, pp.1164~1168 (1997)
26. Li LS, "DNA mismatch repair(MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets", Br J Pharmacol, 158, pp.679~692 (2009)
27. Carethers JM, "Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer", Gastroenterology, 126, pp.394~401 (2004)
28. An JY, "Microsatellite instability in sporadic gastric cancer : its prognostic role and guidance for 5-FU based chemotherapy after R0 resection", Int J Cancer, 131, pp.505~511 (2012)
29. Zuckerman IH, "Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer", J Am Geriatr Soc, 57, pp.1403~1410 (2009)

관련 논문AI추천